🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Tirzepatide nausea management — March 2026 Page 4

Tirzepatide nausea management — March 2026

DataDave Wed, Sep 11, 2024 at 9:14 PM 30 replies 2,103 viewsPage 4 of 6
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
Sep 12, 2024 at 3:25 PM#16

Clinical perspective, offered as context rather than as advice. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

26 24jim_asheville, matt_MKE, Dr.ReproEndo and 23 others
Reply Quote Save Share Report
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Sep 12, 2024 at 5:42 PM#17

One concrete data point for the thread. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

27 0Dr.PathRoch, mona_PHX, andrew_nyc and 24 others
Reply Quote Save Share Report
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Sep 12, 2024 at 7:59 PM#18

A narrower follow-up, since the general answer is now clear:

What distinguishes the nausea you can titrate through from the nausea that means stop?

Last edited: Sep 12, 2024 at 10:59 PM
28 1NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 25 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Sep 12, 2024 at 10:16 PM#19
jason_paloalto said:
One habit that pays for itself: post the method alongside the number.

I read this differently from jason_paloalto, on substance rather than tone. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

Last edited: Sep 13, 2024 at 2:16 AM
29 2lucas_SP_BR, lisa_labSD, adam_van and 26 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Sep 13, 2024 at 12:33 AM#20

Moderator note: a couple of off-topic posts removed. Carry on.

Last edited: Sep 13, 2024 at 4:33 AM
1 24PeptideSynthNJ
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register